MedTrace Logo

Ultra Low Dose CT for CACS and AC of SPECT

NCT02458352 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2019-10-18

Study results available
· View outcomes & findings →

Summary

The aim of the study is to compare the CACS obtained from standard dose CT to the CACS obtained from ultra-low-dose scans. Additionally, the usefulness of ultra-low-dose CT for AC of myocardial perfusion SPECT will be assessed.

Conditions

Interventions

DEVICE

Ultra low dose non-contrast enhanced CT

Non-contrast enhanced CT for CACS and AC using a novel protocol for ultra low dose radiation dose exposure

DEVICE

Standard dose non-contrast enhanced CT

Clinically indicated non-contrast enhanced CT for CACS and AC according to routine protocol

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Valerie Treyer, PhD · University of Zurich

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02458352 on ClinicalTrials.gov